On ECHEMI
Home > Drugs > Portal vein thrombosis
Portal vein thrombosis
Portal vein thrombosis (PT) can occur in any section of the portal vein, and refers to thrombosis in the portal vein trunk, superior mesenteric vein, inferior mesenteric vein or splenic vein. Portal vein thrombosis can cause portal vein obstruction, increase portal vein pressure and intestinal congestion, and is the main disease causing extrahepatic portal hypertension. It is relatively rare in clinical practice. In recent years, with the widespread application of color Doppler and the improvement of diagnostic level, the number of case reports has increased day by day. The cause may be related to systemic or local infection and portal vein congestion. It can also be seen after hepatobiliary surgery and splenectomy. Clinically, more than half of the cases still cannot find the cause. Portal vein thrombosis is divided into primary and secondary. It can be divided into intrahepatic and extrahepatic according to the location, and acute and chronic according to the onset. Clinically, secondary portal vein thrombosis is relatively common, mostly secondary to chronic liver disease and tumor diseases. Extrahepatic portal vein obstruction is mostly secondary to intrahepatic portal hypertension. The main clinical manifestation is abdominal pain, the severity of which depends on the location, rapidity, range and degree of thrombosis. The most prominent symptom of simple extrahepatic portal vein obstruction is esophageal varicose bleeding. Because this disease has no characteristic manifestations, it is easy to misdiagnose clinically.
  • Site of disease:

    Liver blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    Chronic liver disease and tumor disease are more common
  • Related symptoms:

    stomach ache liver enlargement stomach ache abdominal distension abdominal mass
  • Concurrent disease:

Related Drugs
Dipyridamole dispersible tablets
Indication: For the prevention of thromboembolic disease.
Manufacturer:

Beijing Juneng Pharmaceutical Co., Ltd.

Dipyridamole sustained-release capsules
Indication: Prevention and treatment of thromboembolic disease, alone or in combination with aspirin.
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Xuesetong Tablets
Manufacturer:

Yunnan Weihe Pharmaceuticals Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.